Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular DiseasesRinda Devi Bachu, Sai H. S. Boddu, Pallabitha Chowdhury et al.|Pharmaceutics|2018Cited by 408
Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9Zufan Debebe, Sergeï Nekhai, Denitra Breuer et al.|Molecular Pharmacology|2010Cited by 68
Polyamide/Poly(Amino Acid) Polymers for Drug DeliverySai H. S. Boddu, Amit K. Tiwari, Prakash Bhagav et al.|Journal of Functional Biomaterials|2021Cited by 65
Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug effluxPradeep K. Karla, Ashim K. Mitra, Dhananjay Pal et al.|International Journal of Pharmaceutics|2006Cited by 59
Molecular Expression and Functional Evidence of a Drug Efflux Pump (BCRP) in Human Corneal Epithelial CellsPradeep K. Karla, Ashim K. Mitra, Ravinder Earla et al.|Current Eye Research|2009Cited by 57